Market Research Logo

European Market Report for Uterine Fibroid Embolization Devices 2016 - MedCore

European Market Report for Uterine Fibroid Embolization Devices 2016 - MedCore

The UFE market has decreased over the past couple of years as there has been a reduction of active marketing. Moreover, UFE must compete with a wide array of procedures available to treat heavy bleeding due to uterine fibroids. These other treatments and procedures include hysterectomy, pharmacological alternatives, global endometrial ablation, endometrial resection and other minimally invasive surgical procedures. For more price-sensitive countries, such as France, Spain, Italy and Portugal, alternative treatments present significant competition as patients and physicians look for inexpensive methods for the management or treatment of uterine fibroids. Moreover, because of the economic situation, many women are delaying surgical treatments.

Uterine fibroid embolization (UFE), also known as uterine artery embolization (UAE) is a radiology treatment for fibroids. Fibroids, also known as myomas, are masses of muscle tissue and fiber located on the wall of the uterus that can cause heavy bleeding and pain. Fibroids depend on the uterine arteries for nourishment, and they take significant blood supply from these vessels. UFE restricts blood flow to fibroids, causing them to shrink significantly. This procedure does not involve general anesthesia and is appropriate for women who want an alternative to a myomectomy, also known as fibroidectomy. It is a much less invasive way to treat fibroids than a hysterectomy, has a much shorter recovery time and leaves almost no scarring. The effects of UFE on fertility are being researched; some results suggest that fertility after UFE is comparable to fertility after myomectomy.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
1.2.1 Step 1: Project Initiation & Team Selection
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design
1.2.4 Step 4: Performing Primary Research
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
1.2.6 Step 6: Market Forecast and Analysis
1.2.7 Step 7: Identify Strategic Opportunities
1.2.8 Step 8: Final Review and Market Release
1.2.9 Step 9: Customer Feedback and Market Monitoring
COUNTRY PROFILES
2.1 INTRODUCTION
2.1.1.1 Population
2.1.1.2 Median Age
2.1.1.3 GDP Per Capita
2.1.1.4 Price Index
2.2 GERMANY
2.3 FRANCE
2.4 UNITED KINGDOM
2.5 ITALY
2.6 SPAIN
2.7 BENELUX
2.8 SCANDINAVIA
2.9 AUSTRIA
2.10 SWITZERLAND
2.11 PORTUGAL
UTERINE FIBROID EMBOLIZATION DEVICE MARKET
3.1 INTRODUCTION
3.1.1 Microspheres
3.1.2 Polyvinyl Alcohol Particles
3.1.3 Drug-eluting Particles
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Uterine Fibroid Embolization Procedures
3.3.1.1 Microspheres Market
3.3.1.2 PVA Particles Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Gynecological Device Market by Segment, Europe, 2012 – 2022
Chart 1 2: Gynecological Device Market Overview, Europe, 2015 & 2022
Chart 2 1: Country Profile, Germany, 2015
Chart 2 2: Country Profile, France, 2015
Chart 2 3: Country Profile, United Kingdom, 2015
Chart 2 4: Country Profile, Italy, 2015
Chart 2 5: Country Profile, Spain, 2015
Chart 2 6: Country Profile, Benelux, 2015
Chart 2 7: Country Profile, Scandinavia, 2015
Chart 2 8: Country Profile, Austria, 2015
Chart 2 9: Country Profile, Switzerland, 2015
Chart 2 10: Country Profile, Portugal, 2015
Chart 3 1: Uterine Fibroid Embolization Device Market by Segment, Europe, 2015
Chart 3 2: Uterine Fibroid Embolization Device Market Breakdown, Europe, 2015
Chart 3 3: Uterine Fibroid Embolization Device Market Breakdown, Europe, 2022
Chart 3 4: Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022
Chart 3 5: Microspheres Market, Europe, 2012 – 2022
Chart 3 6: PVA Particles Market, Europe, 2012 – 2022
Chart 3 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Europe, 2015
List of Figures
Figure 1 1: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 3)
Figure 1 2: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 3)
Figure 1 3: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (3 of 3)
Figure 1 4: Companies Researched in this Report, Europe, 2015
Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Europe (1 of 3)
Figure 1 6: Factors Impacting the Gynecological Device Market by Segment, Europe (2 of 3)
Figure 1 7: Factors Impacting the Gynecological Device Market by Segment, Europe (3 of 3)
Figure 1 8: Recent Events in Gynecological Device Market, Europe, 2012 – 2016
Figure 1 9: Gynecological Procedures Covered, Europe, 2015
Figure 1 10: Gynecological Device Markets Covered, Europe, 2015 (1 of 2)
Figure 1 11: Gynecological Device Markets Covered, Europe, 2015 (2 of 2)
Figure 1 12: Key Report Updates (1 of 3)
Figure 1 13: Key Report Updates (2 of 3)
Figure 1 14: Key Report Updates (3 of 3)
Figure 1 15: Version History
Figure 2 1: Population by Country, Europe, 2015
Figure 2 2: Population, Benelux, 2015
Figure 2 3: Scandinavia, Europe, 2015
Figure 2 4: GDP per Capita, Europe, 2015
Figure 3 1: Uterine Fibroid Embolization Device Market by Segment, Europe, 2012 – 2022 (€M)
Figure 3 2: Uterine Fibroid Embolization Device Market by Segment, Europe, 2012 – 2022 (US$M)
Figure 3 3: Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (€ and US$)
Figure 3 4: Units Sold by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022
Figure 3 5: Average Selling Price by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (€)
Figure 3 6: Average Selling Price by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (US$)
Figure 3 7: Market Value by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (€M)
Figure 3 8: Market Value by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (US$M)
Figure 3 9: Microspheres Market, Europe, 2012 – 2022 (€ and US$)
Figure 3 10: Units Sold by Country, Microspheres Market, Europe, 2012 – 2022
Figure 3 11: Units per Procedure, Microspheres Market, Europe, 2012 – 2022
Figure 3 12: Average Selling Price by Country, Microspheres Market, Europe, 2012 – 2022 (€)
Figure 3 13: Average Selling Price by Country, Microspheres Market, Europe, 2012 – 2022 (US$)
Figure 3 14: Market Value by Country, Microspheres Market, Europe, 2012 – 2022 (€M)
Figure 3 15: Market Value by Country, Microspheres Market, Europe, 2012 – 2022 (US$M)
Figure 3 16: PVA Particles Market, Europe, 2012 – 2022 (€ and US$)
Figure 3 17: Units Sold by Country, PVA Particles Market, Europe, 2012 – 2022
Figure 3 18: Units per Procedure, PVA Particles Market, Europe, 2012 – 2022
Figure 3 19: Average Selling Price by Country, PVA Particles Market, Europe, 2012 – 2022 (€)
Figure 3 20: Average Selling Price by Country, PVA Particles Market, Europe, 2012 – 2022 (US$)
Figure 3 21: Market Value by Country, PVA Particles Market, Europe, 2012 – 2022 (€M)
Figure 3 22: Market Value by Country, PVA Particles Market, Europe, 2012 – 2022 (US$M)
Figure 3 23: Drivers and Limiters, Uterine Fibroid Embolization Device Market, Europe, 2015
Figure 3 24: Leading Competitors by Country, Uterine Fibroid Embolization Device Market, Europe, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report